Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1015 | 1015 | 1123 | 1010 | 1117 | 1401 |
Fund Return | 1.47% | 1.47% | 12.32% | 0.33% | 2.24% | 3.43% |
Place in category | 446 | 446 | 85 | 478 | 232 | 49 |
% in Category | 44 | 44 | 10 | 60 | 34 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea Korko S K EUR | 3.3B | 1.12 | 1.52 | 0.43 | ||
Nordea Korko I T EUR | 3.3B | 1.10 | 1.51 | 0.42 | ||
Nordea Korko I K EUR | 3.3B | 1.10 | 1.51 | 0.42 | ||
Nordea Korko B T EUR | 3.3B | 1.09 | 1.49 | 0.39 | ||
Nordea Korko B K EUR | 3.3B | 1.09 | 1.49 | 0.39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
OP High Yield A | 458.22M | 1.12 | 1.04 | 2.65 | ||
OP High Yield B | 458.22M | 1.12 | 1.04 | 2.65 | ||
Alandsbanken Euro High Yield B | 231.02M | 1.92 | 0.89 | 2.34 | ||
FIM European HY ESG | 195.38M | 0.94 | 4.31 | 3.28 | ||
Taaleri Higher Yields A | 133.67M | 3.28 | 0.65 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Euro Schatz Future Mar 24 | DE000C7X7UM4 | 16.78 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | XS2406607171 | 2.36 | - | - | |
Electricite de France SA 3.375% | FR0013534336 | 2.13 | - | - | |
VMED O2 UK Financing I PLC 4% | XS2231189924 | 2.04 | - | - | |
Virgin Media Vendor Financing Notes III Designated Activity Company 4.875% | XS2187646901 | 1.95 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review